Additional file 1 of Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

Authors :: Powles, Thomas
Choueiri, Toni K.
Motzer, Robert J.
Jonasch, Eric
Pal, Sumanta
Tannir, Nizar M.
Signoretti, Sabina
Kaldate, Rajesh
Scheffold, Christian
Wang, Evelyn
Aftab, Dana T.
Escudier, Bernard
George, Daniel J.
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 1.

Full Text Access

Tools